Metagenomi - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeMetagenomi
Metagenomi logo

Metagenomi

0 followers

MGX

Performance

About Metagenomi

Metagenomi is an in vivo genome editing company leveraging proprietary technologies to create curative genetic medicines for patients. Founded on the science of metagenomics, the company sources genetic material from natural environments and engineers it into therapeutic tools. It focuses on high-value disease indications with well-understood biology and clearly defined clinical development and regulatory pathways, deploying a diverse and modular genome editing toolbox designed to target site-specific deletions, integrations, and corrections. Headquartered in Emeryville, California, Metagenomi aims to expand its pipeline by leveraging its genetic editing capabilities across the human genome.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Jian Irish

President and CEO

Pamela Wapnick

CFO

Katalin Kauser

SVP, Translational Biology

Mark Leonard

SVP, Technical Operations

Alan Brooks

SVP, Research

Key Facts

HQ Location

Emeryville, United States

Founded

2018

Employees

201 - 500

Status

Public

Website

https://metagenomi.co